Use

The OncoExTra test helps physicians understand changes to a patient's genomic profile by providing a comprehensive molecular picture of advanced, metastatic, refractory, relapsed, or recurrent solid tumors. This detailed information assists in making informed decisions regarding therapeutic treatment plans. It offers ultra-comprehensive genomic profiling by analyzing both DNA and RNA to detect clinically actionable mutations and fusions. The test further refines therapy selection through patient-matched tumor-normal sequencing, which improves estimates of tumor mutational load and can better predict benefits from immunotherapy with fewer false positives.